Nasal nk-t-cell lymphoma relapse can be treated with P-GemOx regimen, SMILE regimen, Sindilizumab and other drugs as appropriate.
In case of relapse of nasal nk-t-cell lymphoma, the patient should go to hematology department to improve the relevant examination, evaluate the condition, and choose the treatment according to the patient’s condition, physical strength and tolerance level, economic situation, and willingness to treat.
Treatment options for relapsed nasal nk-t-cell lymphoma include P-GemOx program (pembrolizumab, gemcitabine, oxaliplatin), SMILE program (levodomain, methotrexate, isocyclophosphamide, etoposide, dexamethasone), and so on; and there are also sindelizumab and pabolizumab in the second-line treatment.
The above drugs and treatment programs should be carried out under the guidance of a professional doctor, and if there is any discomfort, please consult a doctor in time and avoid using drugs alone.